Litcius/Paper detail

Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis–A systematic review and network meta-analysis

Halina Bartosik-Psujek, Łukasz K. Kaczyński, Magdalena Górecka, M. Rolka, Rafał Wójcik, Patrycja Zięba, Marcin Kaczor

2021Multiple Sclerosis and Related Disorders17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCladribineFingolimodTeriflunomideClinical trialMultiple sclerosisExpanded Disability Status ScalePlaceboInternal medicineMeta-analysisOncologyRandomized controlled trialPathologyImmunologyAlternative medicineMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesAmyotrophic Lateral Sclerosis Research
Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis–A systematic review and network meta-analysis | Litcius